Brevetti EPO No.3661514 2025.09.17
Brevetti EPO
(10) Registration Number and Date
2025000413 2025.10.30
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2025/000413 2018.08.03
(40) Publication Number and Date
SM /T/2025/000413 2025.10.30
(30) Priority Details
US 201862639922 P
2018.03.07
US 201862671585 P
2018.05.15
US 201762541591 P
2017.08.04
US 201762584537 P
2017.11.10
(51) IPC Classes
(72) Inventor
(IT) LAMBING, Joseph : 1000 Sierra Point Parkway, Brisbane, CA 94005, US
(IT) GREEN, Eric : 1000 Sierra Point Parkway, Brisbane, CA 94005, US
(IT) ZHANG, David : 140 Park Avenue, San Carlos, CA 94070, US
(IT) SEMIGRAN, Marc J. : 1000 Sierra Point Parkway, Brisbane, CA 94005, US
(IT) CARLSON, Timothy : 2331 Coronet Boulevard, Belmont, CA 94002, US
(IT) LEE, June H. : 1000 Sierra Point Parkway, Brisbane, CA 94005, US
(74) Representative Name
(IT) FERRIERO, Paolo : Via del Serrone, 109, 47897 Fiorentino RSM, SM
(54) Title
(IT) MAVACAMTEN PER L’USO NEL TRATTAMENTO DI CARDIOMIOPATIA IPERTROFICA
(EN) MAVACAMTEN FOR USE IN THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY
(57) Abstract
(58) Citations
Document Type Date Action
Event NameDateStatus
Filing2018.08.03Filed
Brevetto EPO concesso2025.10.30Registered